default author photo

Fabrizio Palmieri

Lazzaro Spallanzani National Institute for Infectious Diseases

Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Division of Infectious Diseases

Rome

Italy

SCHOLARLY PAPERS

4

DOWNLOADS

259

TOTAL CITATIONS

1

Scholarly Papers (4)

Tuberculosis Outcomes Among International Migrants Living in Europe Compared to the Non-Migrant Population: A Systematic Review and Meta-Analysis

Number of pages: 19 Posted: 30 Oct 2024
- Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, - Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Respiratory Infectious Diseases Unit, Lazzaro Spallanzani National Institute for Infectious Diseases, - Department of Internal Medicine and Geriatrics, UniCamillus - Saint Camillus International University of Health Sciences, - Department of Biomedical Science and Human Oncology and - Department of Biomedical Science and Human Oncology
Downloads 87 (767,205)
Citation 1

Abstract:

Loading...

Tuberculosis Outcomes, Migrants, Non-Migrants, Meta-Analysis, Global Health

Tuberculosis Outcomes Among International Migrants Living in Europe Compared to the Non-Migrant Population: A Systematic Review and Meta-Analysis

Number of pages: 17 Posted: 15 Aug 2024
- Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, - Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, - Department of Biomedical Science and Human Oncology, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Respiratory Infectious Diseases Unit, Lazzaro Spallanzani National Institute for Infectious Diseases, - Department of Internal Medicine and Geriatrics, - Department of Internal Medicine and Geriatrics, - Department of Biomedical Science and Human Oncology and - Department of Biomedical Science and Human Oncology
Downloads 71 (879,563)

Abstract:

Loading...

migrants, tuberculosis, TB outcomes, non-migrants, Europe

2.

Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)

Number of pages: 38 Posted: 05 Dec 2022
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Department of Systems Medicine, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Faculty of Medicine and Surgery, University of Rome Tor Vergata - Department of Systems Medicine, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Milan - Clinic of Infectious Diseases and Tropical Medicine, Lazzaro Spallanzani National Institute for Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department and Independent
Downloads 64 (924,743)

Abstract:

Loading...

Interleukin-6 receptor inhibitors, Sarilumab, SARS-CoV-2 infection, Severe COVID-19 pneumonia, randomized clinical trial

3.

Antibodies Contributing to Mycobacterial Growth Restriction in Vitro Display Enhanced Fc-Mediated Phagocytosis

Number of pages: 25 Posted: 23 Aug 2024
Leiden University - Department of Infectious Diseases, Harvard University - Ragon Institute of MGH, MIT and Harvard, Leiden University, Lazzaro Spallanzani National Institute for Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Diseases, Leiden University, Leiden University - Department of Infectious Diseases, Leiden University - Department of Infectious Diseases and Independent
Downloads 24 (1,399,036)

Abstract:

Loading...

4.

Mycobacterial growth control is heterogeneous but maintained during treatment in patients with tuberculosis disease

Number of pages: 23 Posted: 11 Feb 2026
Leiden University - Department of Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Translational Research Unit, Leiden University - Department of Infectious Diseases and Leiden University - Department of Infectious Diseases
Downloads 13 (1,518,554)

Abstract:

Loading...

mycobacteria, tuberculosis, growth inhibition, functional assay, antibodies